October 1, 2003Open Access

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

PICO estructurado

Does a single measurement of NT-proBNP predict mortality better than LVEF, VO2, or HFSS in patients with advanced CHF?

Población

Patients with advanced congestive heart failure (CHF)

Intervención

Single measurement of NT-proBNP

Comparador

LVEF, VO2, or HFSS

Resultado

Mortalityhard clinical

A single NT-proBNP measurement is a superior prognostic marker for mortality in advanced heart failure compared to traditional metrics like LVEF, VO2, and HFSS.

Resumen

A single measurement of NT-proBNP in patients with advanced CHF, can help to identify patients at highest risk of death, and is a better prognostic marker than the LVEF, VO2 or HFSS.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

R Gardner (Wed,) studied this question.

synapsesocial.com/papers/69d72afccd480cb7e5f50efe https://doi.org/https://doi.org/10.1016/j.ehj.2003.07.005

Me gusta

Guardar

Ver artículo completo